Results 21 to 30 of about 45,745 (241)

A case of primary racemose hemangioma with endobronchial lesions demonstrating recurrent hemoptysis initially treated with bronchial arterial embolization

open access: yesRespiratory Medicine Case Reports, 2022
Primary racemose hemangioma of the bronchial artery (RHBA) is one of the causes of massive hemoptysis. A 72-year-old woman was admitted to our hospital with recurrent hemoptysis.
Shun Imai   +14 more
doaj   +1 more source

Hemoptysis in Cancer Patients

open access: yes, 2023
Hemoptysis in cancer patients can occur for various reasons, including infections, tumors, blood vessel abnormalities and inflammatory conditions. The degree of hemoptysis is commonly classified according to the quantity of blood expelled.
Emad D. Singer   +6 more
core   +1 more source

Approach to Hemoptysis

open access: yesMcGill Journal of Medicine, 2022
Hemoptysis is the expectoration of blood from the lower airway. A study in the United Kingdom showed that the annual incidence of hemoptysis in primary care is 0.1%.
Magdalena Peeva
doaj   +1 more source

Bronchial artery embolization in hemoptysis: a systematic review [PDF]

open access: yes, 2017
We systematically reviewed the role of bronchial artery embolization (BAE) in hemoptysis. Literature search was done for studies on BAE published between 1976 and 2016.
Ankur Goyal   +2 more
core   +1 more source

Improvement of pulmonary arterial compliance by pulmonary vasodilator in pulmonary hypertension from combined pulmonary fibrosis and emphysema

open access: yesRespiratory Medicine Case Reports, 2019
Combined pulmonary fibrosis and emphysema (CPFE) is a common but under-recognized syndrome characterized with distinct profiles of both pulmonary fibrosis and emphysema.
Kei Kusaka   +6 more
doaj   +1 more source

Clinical outcomes of cystic fibrosis patients with hemoptysis treated with bronchial artery embolization

open access: yesJornal Brasileiro de Pneumologia, 2021
Objective: Massive hemoptysis is one of the most serious complications in patients with cystic fibrosis (CF). This study aimed to evaluate the hemoptysis-free period following bronchial and non-bronchial artery embolization (BAE/non-BAE) in CF patients ...
Marília Amaral Peixoto da Silveira   +4 more
doaj   +2 more sources

Management of life-threatening hemoptysis

open access: yesJournal of Intensive Care, 2020
It is estimated that 5–14% of patients presenting with hemoptysis will have life-threatening hemoptysis, with a reported mortality rate between 9 and 38%.
Hasmeena Kathuria   +3 more
doaj   +1 more source

ROLE OF BRONCHIAL ARTERY EMBOLIZATION IN THE MANAGEMENT OF HEMOPTYSIS [PDF]

open access: yesNational Journal of Medical Research, 2015
Objective: the goal of this study was to assess the effectiveness and safety of bronchial (BAE) and/or non-bronchial (NBAE) systemic artery embolization in the management of hemoptysis, and the recurrence of hemoptysis within 3 months after embolization
Niranjan Narasimhalu   +4 more
doaj   +1 more source

Association of serum antibodies against the Mycobacterium avium complex and hemoptysis: a cross-sectional study

open access: yesBMC Infectious Diseases, 2021
Background Hemoptysis is very common and can be life threatening in clinical practice for nontuberculous mycobacteria. The serum antibody against the Mycobacterium avium complex (MAC-Ab), the majority of nontuberculous mycobacteria species, is well known
Hiroaki Ogata   +10 more
doaj   +1 more source

A prospective study of the clinical profile of hemoptysis and its correlation with radiological and microbiological findings

open access: yesInternational Journal of Mycobacteriology, 2022
Background: The etiological pattern of hemoptysis has evolved, with pulmonary tuberculosis (PTB) becoming less prevalent as a cause. There is a paucity of literature regarding the spectrum of diseases that present as hemoptysis and the data related to ...
Harveen Kaur, Naveen Pandhi, N C Kajal
doaj   +1 more source

Home - About - Disclaimer - Privacy